Article · 14 Feb 2019
OpinionPublished 7 Jan 2026
Biopharmaceutics Classification System: Drug Performance Prediction
Department of Pharmaceutical Sciences, Crescent Health Institute, Al Noor University, Muscatra, Oman
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The Biopharmaceutics Classification System (BCS) is a key framework for predicting the in vivo performance of oral drugs by assessing solubility, permeability, and dissolution. It aids in formulation development, bioavailability studies, and regulatory decisions on bioequivalence. Advancements in solubility enhancement techniques are crucial for BCS Class II and IV drugs. Permeability and dissolution testing are continuously refined to improve predictive accuracy. The BCS also plays a role in regulatory science, influencing bioequivalence study waivers. Furthermore, it guides drug delivery system selection and emphasizes the importance of gastrointestinal physiology. The BCS framework is evolving with new technologies to enhance its utility in drug development.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 2019
Biopharmaceutics Classification System (BCS) Based Biowaiver Studies of Lenalidomide Capsules (25 mg) – An Alternative to In vivo Bioequivalence Studies for Generic Oncology Drug Products
Article · 16 Jul 2024
Development and Validation of Ultraviolet Spectroscopic Analytical Method for Biopharmaceutical Classification System Class IV Anticancer Drug, Paclitaxel
Research article · 3 May 2016
Comparative studies on the dissolution profiles of oral ibuprofen suspension and commercial tablets using biopharmaceutical classification system criteria
Research article · 31 Oct 2015
Biopharmaceutics classification system- basis for waiver of in-vivobioavailability and bioequivalence studies
More from this journal
The newest in Clinical Pharmacology & Biopharmaceutics.
Research article · 27 Jul 2026
Qualitative LC/MS Assessment of Fenfluramine Hydrochloride After Dilution in Purified Water : A Preliminary Study and Case Report
Article · 20 Jul 2026
Population Pharmacology: Precision Dosing for Diverse Patients
Article · 17 Jul 2026
Therapeutic Drug Monitoring: Optimizing Therapy, Minimizing Toxicity
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical Pharmacology & Biopharmaceutics
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Dr. Omar Al-Farsi”
